Search Results - "de Verneuil, H."

Refine Results
  1. 1

    Effect of tyrosine kinase inhibitors on stemness in normal and chronic myeloid leukemia cells by Charaf, L, Mahon, F-X, Lamrissi-Garcia, I, Moranvillier, I, Beliveau, F, Cardinaud, B, Dabernat, S, de Verneuil, H, Moreau-Gaudry, F, Bedel, A

    Published in Leukemia (01-01-2017)
    “…Although tyrosine kinase inhibitors (TKIs) efficiently cure chronic myeloid leukemia (CML), they can fail to eradicate CML stem cells (CML-SCs). The mechanisms…”
    Get full text
    Journal Article
  2. 2

    Identification of a novel alpha1-antitrypsin variant by de Seynes, Camille, Ged, C, de Verneuil, H, Chollet, N, Balduyck, M, Raherison, C

    Published in Respiratory medicine case reports (01-01-2017)
    “…Abstract Alpha-1-antitrypsin deficiency (A1ATD) is a genetic condition caused by SERPINA1 mutations, which results into decreased protease inhibitor activity…”
    Get full text
    Journal Article
  3. 3

    Acquired erythropoietic uroporphyria and myelodysplastic syndrome cured by bone marrow transplantation by Verneuil, H.

    Published in British journal of dermatology (1951) (01-08-2018)
    “…Linked Article: Podlipnik et al. Br J Dermatol 2018; 179:486–490…”
    Get full text
    Journal Article
  4. 4

    Catalase overexpression reduces UVB-induced apoptosis in a human xeroderma pigmentosum reconstructed epidermis by Rezvani, H R, Ged, C, Bouadjar, B, de Verneuil, H, Taïeb, A

    Published in Cancer gene therapy (01-04-2008)
    “…Xeroderma pigmentosum type C (XPC) is a rare autosomal recessive disorder that occurs due to inactivation of the XPC protein, an important DNA damage…”
    Get full text
    Journal Article
  5. 5

    Hematopoietic stem cell gene therapy of murine protoporphyria by methylguanine-DNA-methyltransferase-mediated in vivo drug selection by RICHARD, E, ROBERT, E, CARIO-ANDRE, M, GED, C, GERONIMI, F, GERSON, S. L, DE VERNEUIL, H, MOREAU-GAUDRY, F

    Published in Gene therapy (01-11-2004)
    “…Erythropoietic protoporphyria (EPP) is an inherited defect of the ferrochelatase (FECH) gene characterized by the accumulation of toxic protoporphyrin in the…”
    Get full text
    Journal Article
  6. 6

    Spatial and temporal control of transgene expression in vivo using a heat-sensitive promoter and MRI-guided focused ultrasound by Guilhon, E., Voisin, P., de Zwart, J. A., Quesson, B., Salomir, R., Maurange, C., Bouchaud, V., Smirnov, P., de Verneuil, H., Vekris, A., Canioni, P., Moonen, C. T. W.

    Published in The journal of gene medicine (01-04-2003)
    “…Background Among the techniques used to induce and control gene expression, a non‐invasive, physical approach based on local heat in combination with a…”
    Get full text
    Journal Article
  7. 7

    A knock-in mouse model of congenital erythropoietic porphyria by Ged, C., Mendez, M., Robert, E., Lalanne, M., Lamrissi-Garcia, I., Costet, P., Daniel, J.Y., Dubus, P., Mazurier, F., Moreau-Gaudry, F., de Verneuil, H.

    Published in Genomics (San Diego, Calif.) (2006)
    “…Congenital erythropoietic porphyria (CEP) is a recessive autosomal disorder characterized by a deficiency in uroporphyrinogen III synthase (UROS), the fourth…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Usefulness of a global clinical ichthyosis vulgaris scoring system for predicting common FLG null mutations in an adult caucasian population by Ezzedine, K., Droitcourt, C., Ged, C., Diallo, A., Hubiche, T., de Verneuil, H., Boralevi, F., Taïeb, A.

    Published in British journal of dermatology (1951) (01-11-2012)
    “…Summary Background  Loss of function FLG alleles were first identified as causative of ichthyosis vulgaris (IV) and were subsequently found to be major…”
    Get full text
    Journal Article
  10. 10

    Successful therapeutic effect in a mouse model of erythropoietic protoporphyria by partial genetic correction and fluorescence-based selection of hematopoietic cells by FONTANELLAS, A, MENDEZ, M, ENRIQUEZ DE SALAMANCA, R, DE VERNEUIL, H, MAZURIER, F, CARIO-ANDRE, M, NAVARRO, S, GED, C, TAINE, L, GERONIMI, F, RICHARD, E, MOREAU-GAUDRY, F

    Published in Gene therapy (01-04-2001)
    “…Erythropoietic protoporphyria is characterized clinically by skin photosensitivity and biochemically by a ferrochelatase deficiency resulting in an excessive…”
    Get full text
    Journal Article
  11. 11

    Analysis of SPINK 5, KLK 7 and FLG genotypes in a French atopic dermatitis cohort by HUBICHE, Thomas, GED, Cécile, BENARD, Antoine, LEAUTE-LABREZE, Christine, MCELREAVEY, Ken, DE VERNEUIL, Hubert, TAÏEB, Alain, BORALEVI, Franck

    Published in Acta dermato-venereologica (2007)
    “…The role of a genetically impaired epidermal barrier as a major predisposing factor in the pathogenesis of atopic disorders is currently under closer…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Congenital erythropoietic porphyria: mutation update and correlations between genotype and phenotype by Ged, C, Moreau-Gaudry, F, Richard, E, Robert-Richard, E, de Verneuil, H

    “…High quality genotype/phenotype analysis is a difficult issue in rare genetic diseases such as congenital erythropoietic porphyria (CEP) or Günther's disease,…”
    Get more information
    Journal Article
  14. 14

    Hepatoerythropoietic Porphyria Caused by a Novel Homoallelic Mutation in Uroporphyrinogen Decarboxylase Gene in Egyptian Patients by Farrag, M S, Mikula, I, Richard, E, Saudek, V, De Verneuil, H, Martásek, P

    Published in Folia biologica (01-01-2015)
    “…Porphyrias are metabolic disorders resulting from mutations in haem biosynthetic pathway genes. Hepatoerythropoietic porphyria (HEP) is a rare type of…”
    Get full text
    Journal Article
  15. 15

    A management algorithm for congenital erythropoietic porphyria derived from a study of 29 cases by Katugampola, R.P., Anstey, A.V., Finlay, A.Y., Whatley, S., Woolf, J., Mason, N., Deybach, J.C., Puy, H., Ged, C., de Verneuil, H., Hanneken, S., Minder, E., Schneider-Yin, X., Badminton, M.N.

    Published in British journal of dermatology (1951) (01-10-2012)
    “…Summary Background  Congenital erythropoietic porphyria (CEP) is an autosomal recessive photomutilating porphyria with onset usually in childhood, where…”
    Get full text
    Journal Article
  16. 16

    Congenital erythropoietic porphyria: a single-observer clinical study of 29 cases by Katugampola, R.P., Badminton, M.N., Finlay, A.Y., Whatley, S., Woolf, J., Mason, N., Deybach, J.C., Puy, H., Ged, C., de Verneuil, H., Hanneken, S., Minder, E., Schneider-Yin, X., Anstey, A.V.

    Published in British journal of dermatology (1951) (01-10-2012)
    “…Summary Background  Congenital erythropoietic porphyria (CEP) is an autosomal recessive cutaneous porphyria caused by decreased activity of uroporphyrinogen…”
    Get full text
    Journal Article
  17. 17

    Rapid analysis and efficient selection of human transduced primitive hematopoietic cells using the humanized S65T green fluorescent protein by MAZURIER, F, MOREAU-GAUDRY, F, DE VERNEUIL, H, MAGUER-SATTA, V, SALESSE, S, PIGEONNIER-LAGARDE, V, GED, C, BELLOC, F, LACOMBE, F, MAHON, F. X, REIFFERS, J

    Published in Gene therapy (01-04-1998)
    “…We have developed an efficient and rapid method to analyze transduction in human hematopoietic cells and to select them. We constructed two retroviral vectors…”
    Get full text
    Journal Article
  18. 18

    Image-guided Control of Transgene Expression Based on Local Hyperthermia by Guilhon, E., Quesson, B., Moraud-Gaudry, F., de Verneuil, H., Canioni, P., Salomir, R., Voisin, P., Moonen, C. T. W.

    Published in Molecular imaging (01-01-2003)
    “…Spatial and temporal control of transgene expression is one of the major prerequisites of efficient gene therapy. Recently, a noninvasive, physical approach…”
    Get full text
    Journal Article
  19. 19

    Proteasome inhibitIon specifically sensitizes leukemic cells to anthracyclin-induced apoptosis through the accumulation of Bim and Bax pro-apoptotic proteins by Pigneux, A., Mahon, F.X., Moreau-Gaudry, F., Uhalde, M., de Verneuil, H., Lacombe, F., Reiffers, J., Milpied, N., Praloran, V., Belloc, F.

    Published in Cancer biology & therapy (01-04-2007)
    “…Proteasome inhibitors are a novel class of compounds that might increase sensitivity to chemotherapy for acute myeloid leukemia (AML). We quantified apoptosis…”
    Get full text
    Journal Article
  20. 20

    Congenital erythropoeietic porphyria treated by haematopoietic stem cell allograft by Lebreuilly-Sohyer, I, Morice, A, Acher, A, Dompmartin, A, Clement, C, de Verneuil, H, Ged, C, Leroy, D, Verneuil, L

    “…Congenital erythropoietic porphyria (CEP) is a genodermatosis associated uroporphyrinogen III synthase deficit that results in porphyrin accumulation in…”
    Get full text
    Journal Article